Bulk active chemical Post approves changes (BACPAC)
BACPAC
Bulk
active chemical Post approves changes
The
guidance provide recommendation to holders of new drug application, abbreviated
new drug application (ANDA), new animal drug application (NADA), abbreviated
new animal drug application (ANADA) drug master files (DMF), veterinary masters
files (VMF), who intend during the post approval period, to change site, site
of manufacture, scale of manufacture, equipment, specification. & manufacturing
process of intermediates in the synthetic pathway lending to the drug substance.
Post
approval includes site of manufacture, scale of manufacture, equipment, specification,
manufacturing process of intermediates in synthetic pathway leading substance.
The
act provides for 4 reporting categories as
1. Prior
approval supplement
2. Supplement-changes
being effected in 30 days
3. Supplement-changes
being effected
4. Annual
report
The
repeating category for a change is based to have on the potential for the
change to have an adverse effect on the identity, Strength, quality purity or
potency of the drug product as these factors may relate to the Safety or effectiveness the drug product.
The guidance applies to synthetic drug synthetic drug substances and synthetic step involved in the preparation of semisynthetic drug.
Post
approval changes affecting the following are not addressed in this document:-
1. synthetic
peptides
2. oligonucleotides.
3. Radiopharmaceuticals
4. Non
synthetic steps for semi-synthetic drug substances
Comments
Post a Comment